Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $32.3636.
A number of equities analysts have recently commented on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, October 8th. Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Sunday, August 3rd. Royal Bank Of Canada reduced their price target on shares of Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Barclays decreased their price objective on Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating for the company in a report on Thursday, November 6th. Finally, Cantor Fitzgerald lowered their target price on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Friday, November 7th.
Get Our Latest Research Report on ACHC
Institutional Inflows and Outflows
Acadia Healthcare Price Performance
Acadia Healthcare stock opened at $14.34 on Monday. The business has a 50-day simple moving average of $22.28 and a 200 day simple moving average of $22.45. Acadia Healthcare has a 52 week low of $14.30 and a 52 week high of $47.08. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of 9.50, a PEG ratio of 4.56 and a beta of 0.97. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $851.57 million during the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the company posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, research analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
- Five stocks we like better than Acadia Healthcare
- How to Use the MarketBeat Stock Screener
- onsemi Places a $6 Billion Bet on Its Own Stock
- What Are Treasury Bonds?
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- Airline Stocks – Top Airline Stocks to Buy Now
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
